COMMUNIQUÉS West-GlobeNewswire

Sanofi: Informations relatives au nombre de droits de vote et d'actions - Juin 2026
10/07/2026
Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L. 233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des Marchés Financiers Sanofi Société [...]
Raw Garden Launches Solventless Live Rosin Joints
10/07/2026
Unique Application Technique Delivers A Smoother, More Consistent Pre-Roll SANTA BARBARA, Calif., July 10, 2026 (GLOBE NEWSWIRE) -- Raw Garden , California’s leader in clean cannabis for over a decade, today announces [...]
Sanofi: Information concerning the total number of voting rights and shares - June 2026
10/07/2026
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
AB Science fait le point sur son programme clinique avec l’arrêt de certaines études cliniques non prioritaires en vue de se concentrer sur deux programmes cliniques
10/07/2026
COMMUNIQUÉ DE PRESSE AB SCIENCE FAIT LE POINT SUR SON PROGRAMME CLINIQUE AVEC L’ARRET DE CERTAINES ETUDES CLINIQUES NON PRIORITAIRES EN VUE DE SE CONCENTRER SUR DEUX PROGRAMMES CLINIQUES Paris, le 10 juillet 2026, 18h [...]
AB Science provides an update on its clinical program, suspending some non-priority clinical trials to focus on two clinical programs
10/07/2026
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON ITS CLINICAL PROGRAM, SUSPENDING SOME NON-PRIORITY CLINICAL TRIALS TO FOCUS ON TWO CLINICAL PROGRAMS Paris, July 10, 2026, 6pm CET AB Science SA (Euronext - FR0010557264 - [...]
Elevar Therapeutics Receives FDA Complete Response Letter for Combination of Rivoceranib and Camrelizumab as a First-line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma
10/07/2026
FORT LEE, N.J., July 10, 2026 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and [...]
Dubai Health and Rush University System for Health Announce Strategic Collaboration to Advance Quality of Care
10/07/2026
Dubai, United Arab Emirates, July 10, 2026 (GLOBE NEWSWIRE) -- Dubai Health has announced a strategic collaboration with Rush University System for Health, one of the leading United States-based academic healthcare [...]
Palisade Bio to Participate in the Leerink Partners Therapeutics Forum
10/07/2026
Management to participate in investor meetings on July 14-15 in Boston Denver, CO, July 10, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical [...]
PatchMD Adds a Topical Berberine Patch to Its Lineup
10/07/2026
The Las Vegas company that introduced the first vitamin patch in 2009 expands its metabolic line with a plant-based patch that delivers berberine and five supporting extracts through the skin. LAS VEGAS, NV, July 10, [...]
FDA Proposes Rule to Modernize Drug Manufacturing Registration
10/07/2026
Proposed rule would streamline registration for advanced distributed manufacturers and increase visibility into foreign drug supply sources Silver Spring, MD, July 10, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug [...]
Clearmind Medicine Responds to the U.S. Administration’s RFI for Addiction Treatment Innovations as Part of the Great American Recovery Initiative
10/07/2026
Vancouver, Canada, July 10, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage a biotech company developing novel, non-hallucinogenic, next-generation, neuroplastogen-derived therapeutics [...]
Communiqué de presse : Sarclisa Escena de Sanofi, la formulation sous-cutanée du Sarclisa, approuvé aux États-Unis comme premier traitement anticancéreux administré via un injecteur portable
10/07/2026
Sarclisa Escena de Sanofi, la formulation sous-cutanée du Sarclisa, approuvé aux États-Unis comme premier traitement anticancéreux administré via un injecteur portable Sarclisa Escena administrée à l’aide de l’injecteur [...]
Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector
10/07/2026
Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector Sarclisa Escena administered via the CirCLIQ ® on-body injector (OBI) offers a treatment [...]
SRX Global Management Team to Host Virtual Fireside Chat on July 14, 2026, and Issues Letter to Shareholders
10/07/2026
Virtual Fireside Chat Scheduled for Tuesday, July 14, 2026, at 10:30 a.m. ET NORTH PALM BEACH, Fla., July 10, 2026 (GLOBE NEWSWIRE) -- SRX Global, Inc. (NYSE American: SRXH) (the "Company", or “SRX”), an AI-enabled [...]
Cosmos Health Launches Subscription Model
10/07/2026
Subscription model already launched with NOOR Collagen in the United States Early data shows a repeat purchase rate above 60% at high margins in excess of 50% Model is designed to drive stronger loyalty, greater [...]
Study Results of Orelabrutinib in Patients with SLE Published in the Journal of Autoimmunity
10/07/2026
BEIJING, July 10, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), today announced that the Journal of Autoimmunity has published results from a clinical study evaluating orelabrutinib, a BTK (Bruton [...]
BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement
10/07/2026
Singapore, July 10, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”) today announced that it has received notification from Nasdaq that the Company has regained compliance with the Nasdaq [...]
Authority Magazine Features Kraig Biocraft Laboratories CEO Kim Thompson as an Industry Disruptor Reshaping the Future of Advanced Materials
10/07/2026
Interview Highlights Thompson's Entrepreneurial Vision and Kraig Labs' Mission to Bring Spider Silk to Commercial Scale ANN ARBOR, Mich., July 10, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB [...]
BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission
10/07/2026
Advances progress towards planned Nasdaq uplisting POMPANO BEACH, Fla., July 10, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company [...]

Pages